Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

381
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
381
Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Teratogenicity01:07

Teratogenicity

4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compulsive sexual behavior disorder (CSBD) and problematic pornography use (PPU): A comprehensive, interdisciplinary, and expert-informed narrative review with suggested future directions.

Journal of behavioral addictions·2026
Same author

Pre-pregnancy body mass index classification and weight gain according to new brazilian protocols and their association with gestational diabetes mellitus.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia·2026
Same author

Routine Postpartum Colostrum Expression and Breastfeeding Outcomes in Women With Diabetes: A Feasibility Trial.

Journal of human lactation : official journal of International Lactation Consultant Association·2026
Same author

Efficacy of Combined Cervical Pessary and Progesterone in Women at High-Risk of Preterm Birth.

Diagnostics (Basel, Switzerland)·2026
Same author

Maternal obesity and healthcare experiences: perceptions and challenges in prenatal and postpartum care.

Psychology, health & medicine·2026
Same author

Association of triglycerides/high-density lipoprotein ratio with cardiometabolic risk factors in children from mothers who had gestational diabetes.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo·2025

Related Experiment Video

Updated: Apr 1, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.9K

Maternal overweight and sexual function in pregnancy.

Meireluci C Ribeiro1, Mary U Nakamura1, Maria R Torloni1

  • 1São Paulo Federal University (UNIFESP), São Paulo, Brazil.

Acta Obstetricia Et Gynecologica Scandinavica
|October 13, 2015
PubMed
Summary

Overweight pregnant women experience decreased sexual function, particularly in the third trimester. This study highlights the impact of pre-pregnancy body mass index on female sexual health during gestation.

Keywords:
Pregnancyobesityoverweightsexual dysfunctionsexuality

More Related Videos

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
05:17

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy

Published on: April 5, 2024

1.5K
Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
06:55

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus

Published on: December 5, 2015

14.3K

Related Experiment Videos

Last Updated: Apr 1, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.9K
Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
05:17

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy

Published on: April 5, 2024

1.5K
Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
06:55

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus

Published on: December 5, 2015

14.3K

Area of Science:

  • Reproductive Health
  • Obesity Research
  • Women's Health

Background:

  • Rising global obesity rates pose risks to female sexual function.
  • Pregnancy can be a period where sexual health is affected by body weight.

Purpose of the Study:

  • To compare sexual function between normal weight and overweight pregnant women.
  • To investigate the relationship between pre-pregnancy BMI and sexual function during pregnancy.

Main Methods:

  • A cross-sectional study of 223 pregnant women (normal weight vs. overweight).
  • Utilized the Female Sexual Function Index (FSFI) to assess sexual function.
  • Analyzed data using statistical tests including t-tests, chi-squared, Kruskal-Wallis, and Pearson's correlation.

Main Results:

  • No significant difference in sexual function between groups in the 2nd trimester.
  • Overweight women showed significantly lower overall sexual function in the 3rd trimester.
  • Lower scores in desire, arousal, lubrication, orgasm, and dyspareunia were noted in overweight women during the 3rd trimester.
  • An inverse correlation was found between pre-pregnancy BMI and 3rd trimester sexual function.

Conclusions:

  • Overweight status is associated with poorer sexual function in the third trimester of pregnancy.
  • Pre-pregnancy BMI is a significant factor influencing sexual health outcomes in pregnant women.